S. 2658Senate113th Congress (2013-2015)In Committee

Accelerating Biomedical Research Act

Sponsored by Tom HarkinSen. Tom Harkin (D-IA)
Introduced July 24, 2014

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
SenateIntro Referral Latest Action

Read twice and referred to the Committee on the Budget.

July 24, 2014

View full timeline
SenateIntro Referral

Introduced in Senate

July 24, 2014

SenateIntro Referral

Sponsor introductory remarks on measure. (CR S4906-4908)

July 24, 2014

SenateIntro Referral

Read twice and referred to the Committee on the Budget.

July 24, 2014

Floor Debate

20 members

What members said about S. 2658 on the floor

10 Republicans10 Democrats
Ted Cruz
Sen. Ted CruzR-TX · Jul 24, 2014

Mr. President, I thank my friend, the junior Senator from Alabama, for his very kind comments and for his relentless leadership in defense of the rule of law and standing against amnesty. What I wish…

Rob Portman
Sen. Rob PortmanR-OH · Jul 24, 2014

Madam President, earlier today the Senate voted to proceed to debate on legislation called the Bring Jobs Home Act. It is about tax reform. It is about the tax system in this country. I am glad we…

Richard J. Durbin
Sen. Richard J. DurbinD-IL · Jul 29, 2014

Mr. President, I want to associate myself with the remarks of the chairwoman of the Appropriations Committee, my chairwoman, Senator Mikulski. I would add perhaps one particular point; that is, this…

Marco Rubio
Sen. Marco RubioR-FL · Jul 24, 2014

Madam President, I ask to be recognized as if in morning business. Thank you, Madam President. I come to the floor today to discuss the ongoing situation in Israel. We all watch with great concern…

Jeff Sessions
Sen. Jeff SessionsR-AL · Jul 24, 2014

Mr. President, we are dealing with a very disturbing crisis on our borders. The situation that has developed is unbelievable. It is unbelievable how rapidly it has developed, but it has, indeed, been…

Show 8 more
Barbara A. Mikulski
Sen. Barbara A. MikulskiD-MD · Jul 29, 2014

What is the parliamentary situation? May I proceed or does the other party wish to--how much time is remaining on our side? With the concurrence of the minority party, I wish to proceed. I know they…

Mitch McConnell
Sen. Mitch McConnellR-KY · Jul 24, 2014

Madam President, I ask unanimous consent that the quorum call be rescinded. Madam President, yesterday Secretary of Defense Chuck Hagel wrote to the majority leader seeking $225 million in additional…

Tom Harkin
Sen. Tom HarkinD-IA · Jul 24, 2014

Mr. President, last year, 2013, marked the 10-year anniversary of the completion of the historic campaign to double funding for the National Institutes of Health. Beginning in fiscal year 1998, I…

Tom Harkin
Sen. Tom HarkinD-IA · Jul 24, 2014

Mr. President, last year, 2013, marked the 10-year anniversary of the completion of the historic campaign to double funding for the National Institutes of Health. Beginning in fiscal year 1998, I…

Sheldon Whitehouse
Sen. Sheldon WhitehouseD-RI · Jul 24, 2014

Thank you, Madam President. This is my 75th ``Time to Wake Up'' speech, something of a minor benchmark, I suppose. I come here urging my colleagues to wake up to the threat of climate change. I do…

Richard J. Durbin
Sen. Richard J. DurbinD-IL · Jul 24, 2014

I ask unanimous consent that the order for the quorum call be rescinded. Madam President, the child refugee crisis on America's border is a human tragedy. Two weeks ago in Chicago I met 70 of these…

Orrin G. Hatch
Sen. Orrin G. HatchR-UT · Jul 24, 2014

Madam President, I wish to compliment the distinguished Senator from Nevada for his very cogent remarks. They are true, and I appreciate his leadership on this matter. Bring Jobs Home Act Madam…

Thomas R. Carper
Sen. Thomas R. CarperD-DE · Jul 29, 2014

Mr. President, first let me express my thanks to Senator Grassley for letting me step ahead of him and I thank the Senator as well for a number of courageous votes today. I also express my gratitude…

Show 11 more
Ted Cruz
Sen. Ted CruzR-TX · Jul 29, 2014

I thank my friend from South Dakota. Mr. President, I am pleased and saddened to stand here in support of my colleagues as we stand united in support of the Nation of Israel. In the last several…

Lindsey Graham
Sen. Lindsey GrahamR-SC · Jul 29, 2014

Mr. President, I return the compliment to Senator McConnell from Kentucky, the Republican leader. I have been here now since 2002. There is no better friend of the State of Israel than Mitch…

Kelly Ayotte
Sen. Kelly AyotteR-NH · Jul 29, 2014

I thank my colleagues, the Senator from South Carolina for his leadership and our leader, the Senator from Kentucky, for the incredible work he has done in supporting our great friend Israel and also…

Jeff Merkley
Sen. Jeff MerkleyD-OR · Jul 29, 2014

I rise today to address a topic that is vital to seniors in Oregon and to seniors across our Nation, and that is our Medicare program. I know how important Medicare is because I grew up in a…

Tammy Baldwin
Sen. Tammy BaldwinD-WI · Jul 24, 2014

Madam President, we have an opportunity to address an issue of concern to foresting communities in Wisconsin and across the Nation in the emergency supplemental appropriations bill now pending before…

John Thune
Sen. John ThuneR-SD · Jul 29, 2014

Mr. President, I wish to end on what my colleagues, the Senator from Kentucky and the leader, Senator McConnell, say. Senator Graham, Senator Ayotte, and I appreciate Senator McConnell's leadership…

Dean Heller
Sen. Dean HellerR-NV · Jul 24, 2014

Madam President, last week the Washington Post ran an opinion piece titled ``Moral clarity in Gaza.'' The thesis of the article states that Israel is not interested in cross-border violence; rather,…

Dianne Feinstein
Sen. Dianne FeinsteinD-CA · Jul 24, 2014

Mr. President, I rise today to introduce bipartisan legislation with my colleagues Senator Portman and Senator Begich that would expand the definition of ``homeless'' used by the U.S. Department of…

Mitch McConnell
Sen. Mitch McConnellR-KY · Jul 29, 2014

Will the Senator yield for a question? We all remember that 10 or 12 years ago Israel--which had previously occupied Gaza for the purpose of preventing these types of devastating attacks--left. They…

Patrick J. Leahy
Sen. Patrick J. LeahyD-VT · Jul 29, 2014

Mr. President, I agree with my distinguished colleague, the senior Senator from Illinois. I think Senator Sanders and Senator McCain showed that things can get done around here. I think of the…

Harry Reid
Sen. Harry ReidD-NV · Jul 29, 2014

Mr. President, the distinguished senior Senator from Delaware and I came to Washington together, and I am so proud of the work he is doing and what he has done. He has been a Member of Congress,…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued July 24, 2014

II

113th CONGRESS

2d Session

S. 2658

IN THE SENATE OF THE UNITED STATES

July 24, 2014

Mr. Harkin introduced the following bill; which was read twice and referred to the Committee on the Budget

A BILL

To prioritize funding for the National Institutes of Health to discover treatments and cures, to maintain global leadership in medical innovation, and to restore the purchasing power the NIH had after the historic doubling campaign that ended in fiscal year 2003.

1.

Short title

This Act may be cited as the Accelerating Biomedical Research Act.

2.

Findings

Congress makes the following findings:

(1)

The National Institutes of Health (referred to in this section as the NIH) is the leading biomedical research entity in the world. It supports researchers in every State as they discover treatments and cures to prevent and reduce human suffering. Thanks in large part to NIH-funded medical research, Americans today are living longer and healthier. Life expectancy in the United States has jumped from 47 years in 1900 to 78 years in 2009, and disability in people over age 65 has dropped dramatically in the past 3 decades.

(2)

Over the past 40 years, NIH-supported research contributed to the discovery of 153 new Food and Drug Administration-approved drugs, vaccines, or new indications for current drugs.

(3)

The application success rate is now at an all-time low. From 1980 to 2003, the last year of the doubling, the grant application success rate ranged between 25 and 35 percent. By 2013, the grant success rate had fallen to 16.8 percent.

(4)

Recent Federal funding cuts threaten to diminish United States leadership in the world. The international community has recognized the role biomedical research plays in generating economic growth. England, China, Brazil, South Korea, India, Singapore, Germany, France and Japan are increasing their investment, despite the worldwide recession. Only the United States has decreased its investment, from 0.215 percent of Gross Domestic Product in 2003 (the last year of the doubling) to 0.174 percent in 2013. In 8 years, if current trends continue, China will surpass the United States in total government biomedical research investment.

(5)

NIH is vital to the United States economy. In fiscal year 2012, the NIH extramural program supported around 50,000 competitive research grants and 300,000 scientists and research personnel at more than 2,500 universities, medical schools, and other research institutions across our 50 States.

(6)

Economists have estimated the return on each dollar of investment in NIH to generate anywhere from $1.80 to $3.20 in economic output. The Federal investment of $3,800,000,000 in the Human Genome Project from 1988 to 2003 helped drive $796,000,000,000 in economic output, which is a return of $141 for every $1 invested.

(7)

In 2013, sales of products built around licensed NIH and Food and Drug Administration inventions included 358 licensees reporting a total of $7,000,000,000 in sales.

(8)

The historic doubling of Federal funding for the National Institutes of Health ended in fiscal year 2003. Since that time, NIH appropriations have not kept up with biomedical inflation. NIH has lost more than 20 percent of its purchasing power for medical research since 2003.

(9)

If NIH had kept up with biomedical inflation, NIH’s appropriation would have totaled $37,000,000,000 in 2013, instead of the $28,900,000,000 that was actually appropriated, a loss of $8,100,000,000 or 28 percent. To restore funding to the 2003 post-doubling level would require Congress to appropriate $46,500,000,000 in fiscal year 2021, the final year of the Budget Control Act of 2011 (Public Law 112–25).

(10)

High health care costs from a variety of common conditions threaten Federal, State, and local budgets, as well as the budgets of American families. Recent estimates indicate that the economic costs of Alzheimer’s disease is over $200,000,000,000 each year but will rise to over $1,000,000,000,000 by 2050 unless a prevention or cure is found. In 2006, economists found that a future 1 percent reduction in mortality rates from cancer would save $500,000,000,000 to current and future Americans. A cure for cancer was estimated to save $50,000,000,000,000 to Americans, more than 3 times the gross domestic product of the United States in 2012. The Centers for Disease Control and Prevention reports that annual costs from undiagnosed diabetes was $245,000,000,000 each year. And a recent study projects that by 2030, nearly 44 percent of the United States population will face some form of cardiovascular disease costing a total of $1,208,000,000,000 between 2012 and 2030.

(11)

Budget cap adjustments are how Congress traditionally prioritizes areas of spending that produce economic growth and reduce costs that contribute to the Federal debt.

3.

Cap adjustment

Section 251(b)(2) of the Balanced Budget and Emergency Deficit Control Act of 1985 (2 U.S.C. 901(b)(2)) is amended—

(1)

by redesignating subparagraph (D) as subparagraph (E); and

(2)

by inserting after subparagraph (C), the following:

(D)

National Institutes of Health

(i)

In general

If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the National Institutes of Health at the Department of Health and Human Services (75–9915–1–1–552), then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

(I)

for fiscal year 2015, $3,000,000,000 in additional new budget authority;

(II)

for fiscal year 2016, $6,300,000,000 in additional new budget authority;

(III)

for fiscal year 2017, $8,100,000,000 in additional new budget authority;

(IV)

for fiscal year 2018, $10,000,000,000 in additional new budget authority;

(V)

for fiscal year 2019, $12,000,000,000 in additional new budget authority;

(VI)

for fiscal year 2020, $14,100,000,000 in additional new budget authority; and

(VII)

for fiscal year 2021, $16,300,000,000 in additional new budget authority.

(ii)

Definitions

As used in this subparagraph:

(I)

Additional new budget authority

The term additional new budget authority means the amount provided for a fiscal year, in excess of $29,926,104,000, in an appropriation Act and specified to support the National Institutes of Health.

(II)

National Institutes of Health

The term National Institutes of Health means the appropriations accounts that support the various institutes, offices, and centers that make up the National Institutes of Health.

.